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Streptococcus pneumoniae, Haemophilus inﬂ  uenzae, 
Moraxella catarrhalis, and Staphylococcus aureus often 
colonize the nasopharynx. Children are susceptible to bac-
terial infections during or soon after upper respiratory tract 
infection (URI). We describe colonization with these 4 bac-
teria species alone or in combination during URI.  Data were 
from a prospective cohort of healthy children 6 to 36 months 
of age followed up for 1 year. Analyses of 968 swabs from 
212 children indicated that S. pneumoniae colonization is 
negatively associated with colonization by H. inﬂ  uenzae. 
Competitive interactions shifted when H. inﬂ  uenzae and M. 
catarrhalis colonized together. In this situation, the likeli-
hood of colonization with all 3 species is higher. Negative 
associations were identiﬁ  ed between S. pneumoniae and S. 
aureus and between H. inﬂ  uenzae and S. aureus. Polymi-
crobial interactions differed by number and species of bac-
teria present. Antimicrobial therapy and vaccination strate-
gies targeting speciﬁ  c bacterial species may alter the ﬂ  ora 
in unforeseen ways.  
S
treptococcus pneumoniae,  Haemophilus inﬂ  uenzae, 
Moraxella catarrhalis, and Staphylococcus aureus of-
ten asymptomatically colonize the nasopharynx of young 
children and are also associated with disease. S. pneu-
moniae, H. inﬂ  uenzae, and M. catarrhalis are the 3 most 
common otitis media pathogens (1,2). S. pneumoniae are 
also common causes of pneumonia, sepsis, and meningitis 
in young children (3). The proportion of young children 
colonized with any of these 3 bacteria species can be >50% 
in certain populations (4–6).  S. aureus strains colonize up 
to 35% of young children and are associated with a wide 
range of diseases including soft tissue infections, sepsis, 
and pneumonia (7,8). Increases in the incidence of disease 
caused by community-acquired methicillin-resistant S. au-
reus are of great concern (9).
Host factors have been shown to inﬂ  uence coloniza-
tion with S. pneumoniae, H. inﬂ  uenzae, M. catarrhalis, and 
S. aureus. These include host immunity, age, gender, race, 
out-of-home daycare, breastfeeding, and environmental 
exposure to tobacco smoke (10).  The magnitude of host 
effects may differ by bacteria species.
Interactions between bacteria inﬂ  uence which species 
persist in the nasopharynx (11–13). Bacteria species may 
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be positively associated; this occurs when they are found 
together more often than would be expected by chance. A 
negative association could occur when bacteria compete 
within same environment. Several studies have described 
a negative association between S. pneumoniae and S. au-
reus  (12–16). Understanding of interactions between S. 
pneumoniae, H. inﬂ  uenzae, M. catarrhalis, and S. aureus 
is limited. 
The nasopharyngeal ﬂ  ora change over time; the level 
of bacteria colonization is higher during upper respiratory 
infection (URI) (6,17). Knowledge is lacking regarding S. 
pneumoniae, H. inﬂ  uenzae, M. catarrhalis, and S. aureus 
interactions during URI because colonization studies either 
do not examine competitive interactions among all 4 patho-
gens or focus on healthy children (5,11,16,18). Children 
are susceptible to secondary bacterial infections during and 
after URI (19–21). 
A better understanding of polymicrobial interactions 
in the nasopharynx is important for several reasons. Colo-
nization is the initial step in the disease process (22, 23). 
Colonized children serve as reservoirs for bacterial trans-
mission to others in the community (24). Additionally, an-
tibimicrobial drugs or vaccines, which target speciﬁ  c bac-
teria species, may alter polymicrobial interactions in the 
nasopharynx and have unanticipated consequences (25,26). 
The goals of our study were to 1) describe the prevalence 
of colonization with S. pneumoniae, H. inﬂ  uenzae, M. ca-
tarrhalis, and S. aureus; 2) evaluate interactions between S. 
pneumoniae, H. inﬂ  uenzae, M. catarrhalis, and S. aureus; 
and 3) estimate the effect of host factors on colonization 
with S. pneumoniae, H. inﬂ  uenzae, M. catarrhalis, and S. 
aureus after a URI in a prospective cohort of young chil-
dren. 
Methods
Study Design and Participants
We used data from a prospective study of otitis media 
complications of URI in children at the University of Texas 
Medical Branch (UTMB) at Galveston (19,26). The study 
was reviewed and approved by the UTMB Institutional 
Review Board. The parents of healthy children 6 months 
through 3 years of age, who were receiving medical care at 
UTMB from January 2003 through March 2007, were in-
vited to enroll their children. Children with chronic medical 
problems and anatomic or physiologic defects of the ear or 
nasopharynx were excluded. 
At enrollment, we collected information about de-
mographic and URI risk factors. Parents were asked to 
describe their child’s race and ethnicity. We also ob-
tained information regarding the number of weeks the 
child had been breast-fed and the number of hours and 
days/week the child currently attended day care. We 
ascertained environmental exposure to tobacco smoke 
based on self-reports of whether any household members 
smoked cigarettes in the home. 
The children in our study were followed up for 1 year. 
We requested that parents notify study staff when the child 
began to exhibit URI symptoms including nasal conges-
tion, rhinorrhea, cough, sore throat, or fever. A study 
physician saw children as soon as possible after the onset 
of URI symptoms.  At each study visit, the study physi-
cian obtained information regarding speciﬁ  c URI symp-
toms and examined the child’s ears. The children were 
then monitored closely for 3 weeks for the development 
of otitis media. The study physician collected a nasopha-
ryngeal swab during the visit for each URI episode and 
when acute otitis media or sinusitis was diagnosed. URI 
episodes were categorized as the same episode if symp-
toms persisted. An episode of URI was considered new 
when symptoms of the previous episode subsided and the 
parents noted new symptoms of URI as described above. 
Given our prospective study design, many children had 
>1 URI episode and some had >1 visit/URI episode. We 
collected 1 swab/physician visit. Data regarding antimi-
crobial drug therapy during the past 7 days were collected 
by medical record review. A description of the methods is 
provided elsewhere (19,26).
A total of 294 children were enrolled in the original 
study (19,26). Included in these analyses are data from 212 
(72%) children who experienced at least 1 URI, were seen 
by a study physician, and had a nasopharyngeal swab col-
lected for bacterial culture. Thus, we excluded 82 children 
who did not have a URI and a swab for bacterial culture.   
Of these 82 children without URI visits, 35 (59%) were 
lost to follow-up in the ﬁ  rst 6 months, 13 (38%) were lost 
to follow-up in months 7–11, and 34 (17%) completed 1 
year of follow up. 
Mini-Tip Culturette  kits (Becton Dickinson Micro-
biology Systems, Cockeysville, MD, USA) were used for 
sample collection. Each swab was streaked onto 1 blood 
and 1 chocolate agar plate. We subcultured and identiﬁ  ed 
suspected isolates of each species as follows: S. pneumo-
niae isolates were identiﬁ  ed by using the optochin disk 
susceptibility test (Taxo P, Becton Dickinson Microbiol-
ogy Systems), H. inﬂ  uenzae isolates were identiﬁ  ed by the 
Haemophilus ID Quad Plate with Growth Factors (Becton 
Dickinson Microbiology Systems), M. catarrhalis isolates 
were identiﬁ  ed by the API QuadFerm assay (bioMérieux, 
Inc., Hazelwood, MO, USA), and S. aureus isolates were 
identiﬁ  ed by coagulase, catalase, and latex agglutination 
test (Staphaurex Plus, Remel, Lenexa, KS, USA).
Statistical Methods
The main outcomes of interest were the relationships 
between bacteria during URI. All statistical analyses were 
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conducted by using SAS version 9.1 (SAS Institute, Inc., 
Cary, NC, USA). We examined colonization by S. pneumo-
niae, H. inﬂ  uenzae, M. catarrhalis, and S. aureus by using 
repeated measures logistic regression with generalized es-
timating equations and an autoregressive correlation struc-
ture (AR1) using the procedure PROC GENMOD (SAS 
Institute, Inc.). Because each child could potentially have 
multiple URI episodes and contribute multiple bacterial 
swabs to the analysis, we used a repeated measures design 
to take into account variability of multiple samples from 
each child. To examine the effect of covariates on each bac-
teria species, we modeled colonization by S. pneumoniae, 
H. inﬂ  uenzae, and M. catarrhalis separately. We did not 
separately model the outcome of colonization by S. aureus 
because of low numbers of isolates obtained. Each model 
included the presence or absence of other bacteria species, 
as well as potential sampling-time confounders comprising 
time of swab collection after URI onset, antimicrobial drug 
therapy within the past 7 days, and age of the child at the 
time of swab collection. Host factors included in the model 
were gender, race, day care, breast-fed for >4 months, and 
environmental exposure to tobacco smoke.
Results 
Characteristics of the study participants are shown in 
Table 1. The median age of study participants was 12.0 
months; mean age was 14.1 (SD 7.4) months. Most chil-
dren were white, were cared for at home, and had not been 
breast-fed for >4 months. Children were followed up for a 
median of 12 months and a mean of 10.7 (SD 2.8) months.
Individual children contributed between 1 and 20 swab 
specimens each (mean [SD] and median of 4.6 [3.8] and 3.0 
swabs, respectively) from 1 to 18 URI episodes each (mean 
[SD] and median of 4.0 [3.3] and 3.0 episodes, respective-
ly). Overall, at least 1 of the 4 species was isolated from 
841 of 968 swab samples (86.9%) from 212 children. Of 
the 968 swabs, S. pneumoniae was present in 441 (45.6%), 
H. inﬂ  uenzae was present in 314 (32.4%), and M. catarrha-
lis was the most common bacteria species identiﬁ  ed in 611 
(63.1%) swabs. S. aureus was relatively rare in comparison; 
69 swabs (7.1%) were positive for this species. The distri-
bution and colonization patterns of the 4 bacteria species by 
swab and number of URI visits are shown in Table 2.
Most swabs (849 [87.7%]) were collected within 7 
days of URI onset; 119 (12.3%) were taken 8–30 days after 
URI onset. Of the 968 swab samples, only 54 (5.6%) were 
collected from children who had taken antimicrobial drugs 
within the past 7 days. Therefore, most swabs were collect-
ed from children who were not taking antimicrobial drugs 
at the time of swab collection (94.5%). Of the 212 children, 
205 (>96%) had received at least 1 dose of the 7-valent 
pneumococcal conjugate vaccine (PCV7) at the time of en-
rollment. Most of the children had received all age-appro-
priate scheduled PCV7 vaccinations at their URI visit, 666 
(69%) of samples were collected from children who had 
received the age-appropriate number of PCV7 doses at the 
time of swab collection. There was no association between 
being up to date with PCV7 vaccination and colonization 
with S. pneumoniae (p = 0.71). We did not further examine 
the effect of the pneumococcal vaccine further because of 
the high level of coverage in our study population. 
Repeated measures logistic regression models predict-
ing colonization by S. pneumoniae, H. inﬂ  uenzae, or M. 
catarrhalis are shown in Table 3. A positive association 
between bacteria is indicated by an odds ratio (OR) ≥1; a 
negative association is indicated by an OR <1. An OR of 
1.0, or any 95% conﬁ  dence interval that includes 1.0 indi-
cates no signiﬁ  cant association. The model predicting colo-
nization by S. pneumoniae indicated that colonization by H. 
inﬂ  uenzae was negatively associated with S. pneumoniae. 
However, when H. inﬂ  uenzae and M. catarrhalis colonized 
together, they were positively associated with S. pneumo-
niae colonization. Colonization by S. aureus resulted in 
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Table 1. Characteristics of study participants enrolled through the 
University of Texas Medical Branch, Galveston, Texas, USA, 
2003–2007*
Characteristic No. (%) 
Age at enrollment, mo  
   6–<12  92 (43.4) 
   12–<18  62 (29.2) 
   18–<24  30 (14.2) 
   24–<36  28 (13.2) 
Gender 
    F  103 (48.6) 
    M  109 (51.4) 
Race
    White  124 (58.5) 
    Black  62 (29.2) 
    Asian  6 (2.8) 
    Other  20 (9.4) 
Ethnicity 
    Hispanic or Latino  95 (44.8) 
    Not Hispanic 117 (55.2) 
Day care† 
   No  147 (69.7) 
   Yes  64 (30.3) 
Breast-fed for >4 mo 
   No  173 (82.0) 
   Yes  38 (18.0) 
Environmental exposure to tobacco smoke‡ 
  No  145 (68.4) 
  Yes  67  (31.6) 
*Data given for 212 participants who experienced at least 1 upper 
respiratory infection, were seen by a study physician, and had a 
nasopharyngeal swab collected for bacterial culture. An additional 82 
enrollees were excluded from the study because they did not experience 
an upper respiratory infection and did not have a nasopharyngeal swab 
collected for bacterial culture. Some numbers do not add up to 212 
because of missing data.  
†No. hours and days/week in day care were grouped into any or none. 
‡Environmental exposure to tobacco smoke was based on parental self-
report.   Microbial Interactions during URIs
a 40% reduction in the odds of S. pneumoniae coloniza-
tion. Older children were less likely to be colonized with S. 
pneumoniae; each 1-month increase in age was associated 
with a 2% decrease in the odds of S. pneumoniae coloni-
zation (Table 3). Antimicrobial drug therapy in the past 7 
days was associated with decreased odds of S. pneumoniae 
colonization. The timing of swab collection after onset of 
URI symptoms and host characteristics such as gender, 
race, daycare, breastfeeding, and environmental exposure 
to tobacco smoke were not associated with colonization by 
S. pneumoniae. 
In our model examining H. inﬂ  uenzae colonization as 
the outcome, H. inﬂ  uenzae was negatively associated with 
S. pneumoniae, M. catarrhalis, and S. aureus (Table 3). In 
contrast to their association with S. pneumoniae coloniza-
tion, age and antimicrobial drug therapy during the past 7 
days were not signiﬁ  cantly associated with colonization 
by H. inﬂ  uenzae. Host characteristics were associated with 
colonization by H. inﬂ  uenzae. Male gender and out-of-
home daycare were associated with increased odds of H. 
inﬂ  uenzae colonization. White race was associated with 
decreased odds of H. inﬂ  uenzae colonization.
Our third model examined factors associated with col-
onization by M. catarrhalis (Table 3).  H. inﬂ  uenzae was 
negatively associated with colonization by M. catarrha-
lis, but when H. inﬂ  uenzae and S. pneumoniae colonized 
together, they were positively associated with coloniza-
tion by M. catarrhalis. Older children were less likely to 
be colonized with M. catarrhalis; each 1-month increase 
in age was associated with a 2% decrease in the odds of 
M. catarrhalis colonization (Table 3). Antimicrobial drug 
therapy in the past 7 days was associated with decreased 
odds of M. catarrhalis colonization. The timing of swab 
collection after onset of URI symptoms and host charac-
teristics such as gender, race, daycare, breastfeeding, and 
environmental exposure to tobacco smoke were not associ-
ated with colonization by M. catarrhalis.
Discussion 
We describe nasopharyngeal colonization of children 
with S. pneumoniae, H. inﬂ  uenzae, M. catarrhalis, and S. 
aureus alone or in combination during URI. Our models 
predicting S. pneumoniae colonization indicated that H. 
inﬂ  uenzae is negatively associated with S. pneumoniae. 
However, when H. inﬂ  uenzae was present with M. ca-
tarrhalis, odds of S. pneumoniae colonization increased 
by >2-fold. Models predicting H. inﬂ  uenzae colonization 
indicated a negative association with S. pneumoniae, M. 
catarrhalis, and S. aureus. Competitive interactions be-
tween bacteria are complex after URI and may shift from 
negative to positive when additional bacteria species are 
present. Modeling S. pneumoniae, H. inﬂ  uenzae, and M. 
catarrhalis colonization separately showed that gender, 
race, and daycare were associated with colonization by H. 
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Table 2. Distribution of bacteria on nasopharyngeal swabs collected from children with URI, University of Texas Medical Branch,
Galveston, Texas, USA, 2003–2007* 
No. (%) URI visits† 
Variable
Total no. (%) 
URI visits  1 2 3–4 5–6 >6
Total no. patients  212 46 (21.7)  42 (19.8)  38 (17.9)  37 (17.4)  49 (23.1) 
Total no. swabs  968 46 (4.8)  84 (8.7)  128 (13.2)  201 (20.8)  509 (52.6) 
Bacteria present  (% of no. of swabs in each visit category) 
  0  127 (13.1)  9 (19.6)  9 (10.7)  13 (10.2)  19 (9.4)  77 (15.1) 
 1 
  Streptococcus  pneumoniae 79 (8.2)  1 (  2.2)  9 (10.7)  15 (11.7)  20 (10.0)  34 (6.7) 
  Haemophilus  influenzae 86 (8.9)  7 (15.2)  10 (11.9)  11 (8.6)  18 (9.0)  40 (7.9) 
  Moraxella  catarrhalis 201 (20.8)  10 (21.7)  12 (14.3)  27 (21.1)  41 (20.4)  111 (21.8) 
  Staphylococcus  aureus 24 (2.5)  1 (2.2)  2 (2.4)  2 (1.6)  3 (1.5)  16 (3.1) 
 2 
  S.  pneumoniae, H. influenzae 28 (2.9)  1 (2.2)  2 (2.4)  4 (3.1)  8 (4.0)  13 (2.6) 
  S.  pneumoniae, M. catarrhalis 187 (19.3)  13 (28.3)  20 (23.8)  24 (18.8)  36 (17.9)  94 (18.5) 
  S.  pneumoniae, S. aureus 8 (0.8)  0 1 (1.2)  1 (1.0)  4 (2.0)  2 (0.4) 
  H.  influenzae, M. catarrhalis 67 (6.9)  2 (4.4)  5 (6.0)  7 (5.5)  13 (6.5)  40 (7.9) 
  H.  influenzae, S. aureus 3 (0.3)  0 1 (1.2)  0 1 (0.5)  1 (0.2) 
  M.  catarrhalis, S. aureus 17 (1.8)  0 2 (2.4)  3 (2.3)  2 (1.0)  10 (2.0) 
 3
    S. pneumoniae,  H. influenzae, M. catarrhalis 124 (12.8)  2 (4.4)  8 (9.5)  19 (14.8)  31 (15.4)  64 (12.6) 
    S. pneumoniae, H. influenzae, S. aureus 2 (0.2)  0 1 (1.2)  0 0 1 (0.2) 
    S. pneumoniae, M. catarrhalis, S. aureus 11 (1.1)  0 1 (1.2)  2 (1.6)  4 (2.0)  4 (0.8) 
    H. influenzae, M. catarrhalis, S. aureus 2 (0.2)  0 0 0 1 (0.5)  1 (0.2) 
  4 2 (0.2)  0 1 (1.2)  0 0 1 (0.2) 
*URI, upper respiratory tract infection. 
†Data are presented as no. of physician visits/child. Because of our prospective study design, many children had >1 URI episode during the follow-up 
period, and some had >1 physician visit/URI episode. One nasopharyngeal swab sample was taken at each physician visit. RESEARCH
inﬂ  uenzae, but not with colonization by either S. pneumo-
niae or M. catarrhalis. 
Jacoby et al. used a multivariate random effects mod-
el to examine S. pneumoniae colonization in Aboriginal 
and non-Aboriginal children in Australia (11). Their study 
differed from ours in that they examined the relationship 
between  S. pneumoniae, H. inﬂ  uenzae,  M. catarrhalis, 
and S. aureus in pairwise combinations. These research-
ers also examined healthy children; we examined children 
who had a URI. Jacoby et al. observed positive associa-
tions between pairwise combinations of S. pneumoniae 
and H. inﬂ  uenzae and between S. pneumoniae and M. ca-
tarrhalis. They did not identify an association between S. 
pneumoniae and S. aureus or between H. inﬂ  uenzae and 
S. aureus (11).
Our results conﬁ  rm a recent report describing a nega-
tive association between H. inﬂ  uenzae and S. aureus in 
HIV-negative children (12). Our data also support a grow-
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Table 3. Predicted outcome of colonization with Stretococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis in young 
children after upper respiratory tract infection (968 swabs from 212 children; see Table 2)* 
OR (95% CI)
Parameters  S. pneumoniae H. influenzae M. catarrhalis
H. influenzae x M. catarrhalis  (p = 0.0003)†
 Neither  (reference)  1.0 – –
 H.  influenzae only  0.59 (0.40–0.88) ––
 M.  catarrhalis only  1.31 (0.95–1.81)  – –
 Both  2.13 (1.35–3.38) ––
S. pneumoniae x M. catarrhalis (p = 0.08)†
Neither (reference) – 1.0 –
 S.  pneumoniae only  –  0.52 (0.32–0.83) –
 M.  catarrhalis only  – 0.45 (0.29–0.69) –
 Both  – 0.82  (0.52–1.30)  –
H. influenzae x S. pneumoniae (p<0.0001)†
 Neither  (reference)  – – 1.0
 H.  influenzae only  – – 0.44 (0.30–0.63)
 S.  pneumoniae only  – – 1.22 (0.88–1.70) 
 Both  – – 2.09 (1.30–3.37)
S. aureus
Absent (reference) 1.0 1.0 1.0
 Present  0.60 (0.36–0.99) 0.36 (0.17–0.76) 0.72 (0.42–1.25) 
Age (1-mo increase)‡  0.98 (0.96–1.00) 1.01 (0.98–1.03)  0.98 (0.97–1.00)
Antimicrobial drug therapy in past 7 days 
No (reference) 1.0 1.0 1.0
 Yes  0.40 (0.22–0.72) 1.21 (0.69–2.13)  0.52 (0.28–0.96)
Time after URI onset, d 
<7 (reference) 1.0 1.0 1.0
  >7  1.47 (0.96–2.27)  1.10 (0.70–1.73)  1.21 (0.81–1.80) 
Gender 
F (reference) 1.0 1.0 1.0
 M  1.05  (0.80–1.38)  1.44 (1.08–.93) 0.86 (0.65–1.14) 
Race
Not white (reference)  1.0 1.0 1.0
 White  1.12  (0.84–1.48)  0.42 (0.31–0.57) 0.80 (0.60–1.07) 
Day care 
No (reference) 1.0 1.0 1.0
 Yes  1.32  (0.97–1.80)  1.51 (1.09–2.09) 1.09 (0.79–1.50) 
Breast-fed >4 mo  
No (reference) 1.0 1.0 1.0
  Yes  0.94 (0.69–1.29)  0.92 (0.65–1.29)  0.81 (0.59–1.12) 
Environmental exposure to tobacco smoke  
No (reference) 1.0 1.0 1.0
  Yes  1.13 (0.84–1.52)  0.93 (0.69–1.27)  0.91 (0.67–1.23) 
*OR, odds ratio; CI, confidence interval. Significant ORs and 95% CIs are shown in boldface. Each model included variables representing presence or 
absence of other bacteria as well as all other variables listed. We did not model colonization of S. aureus because of low prevalence of this species 
(69/968 positive swabs).  
†p value from logistic regression model for overall significance of bacterial interaction. 
‡Age (mo) of the child at the time of swab collection. Microbial Interactions during URIs
ing body of literature describing negative associations be-
tween S. pneumoniae and S. aureus (12–15).  For example, 
a cross-sectional study of 790 children younger than 40 
months identiﬁ  ed a negative association between S. pneu-
moniae colonization and S. aureus (OR 0.47; 95% conﬁ  -
dence interval 0.28–0.78) (13). 
An in vivo mouse model of competitive interactions 
between S. pneumoniae and H. inﬂ  uenzae has suggested 
mechanisms to explain our observations (27). Both S. pneu-
moniae and H. inﬂ  uenzae successfully colonized BALBc/
SCID mice when each bacteria species was injected sepa-
rately. However, S. pneumoniae was cleared rapidly when 
H. inﬂ  uenzae was present in a co-colonization model. The 
competitive interaction between H. inﬂ  uenzae and S. pneu-
moniae was dependent on complement and neutrophils 
(27). These researchers proposed that H. inﬂ  uenzae cellular 
components activate the host innate immune response, thus 
killing S. pneumoniae (27). M. catarrhalis was not exam-
ined in this model, but our data suggest that the additional 
presence of M. catarrhalis might alter the competitive bal-
ance between S. pneumoniae and H. inﬂ  uenzae and that all 
3 bacteria species would successfully colonize. 
In vitro studies have also demonstrated competition 
between H. inﬂ  uenzae and S. pneumoniae but predicted 
that S. pneumoniae should inhibit the growth of H. inﬂ  u-
enzae. Neuraminidase A is produced by S. pneumoniae and 
cleaves sialic acid. It has been shown to remove sialic acid 
from lipopolysaccharides of H. inﬂ  uenzae strains (28), po-
tentially giving pneumococci a competitive advantage by 
making H. inﬂ  uenzae more susceptible to complement-me-
diated clearance. Furthermore, in vitro co-culture experi-
ments indicate that S. pneumoniae can inhibit H. inﬂ  uenzae 
through the action of hydrogen peroxide (29). Interference 
between S. pneumoniae and S. aureus may also be caused 
by hydrogen peroxide production by S. pneumoniae (30). 
Our results indicate that antimicrobial drug therapy 
in the past 7 days was associated with a lower prevalence 
of colonization with S. pneumoniae or M. catarrhalis. In 
contrast, antimicrobial drug therapy in the past 7 days was 
not associated with colonization by H. inﬂ  uenzae. Varon et 
al. studied the effect of antimicrobial drugs on colonization 
with S. pneumoniae, H. inﬂ  uenzae, and M. catarrhalis in 
a cohort of young children with URI (31). Children in this 
study received antimicrobial drugs for a mean treatment pe-
riod of 8 days. Swab samples were taken before treatment 
and on days 2 through 6 after treatment. Results showed 
that colonization by S. pneumoniae, H. inﬂ  uenzae, and M. 
catarrhalis decreased after antimicrobial drug therapy (31). 
The magnitude of the effect differed by bacteria species 
and the speciﬁ  c antimicrobial drug prescribed. In general, 
antimicrobial drugs were less effective for reducing coloni-
zation with H. inﬂ  uenzae than with S. pneumoniae and M. 
catarrhalis (31). 
The effect of age, gender, race, and breastfeeding on 
colonization differs by population studied (10). Daycare 
has consistently been associated with increased levels of 
colonization with S. pneumoniae, H. inﬂ  uenzae, and M. 
catarrhalis (10), as has exposure to other children in the 
household (32,33). Our study was limited by lack of data 
on age and number of siblings or other potential confound-
ers such as household crowding and socioeconomic status. 
Our study had additional limitations. A cross-sectional 
study of S. aureus and S. pneumoniae colonization indicat-
ed a negative association between PCV7 vaccine serotypes 
and S. aureus (15). No association was found between S. 
pneumoniae nonvaccine types and S. aureus. We were un-
able to examine the association between S. pneumoniae se-
rotype and colonization. Along these lines, we did not have 
data regarding H. inﬂ  uenzae type B vaccination status and 
did not serotype our H. inﬂ  uenzae strains. Therefore, we 
were also unable to evaluate the effect of this vaccination 
on polymicrobial colonization. 
Nasopharyngeal colonization likely involves a com-
plex combination of factors including host characteristics 
that inﬂ  uence exposure to speciﬁ  c bacterial species, host 
immune responses that may result in killing the bacteria, 
and direct competitive interactions between bacteria spe-
cies. In addition to the inhibiting effects of neuraminidase 
A and hydrogen peroxide already described, competitive 
interactions between bacteria may also include the secre-
tion of small peptide inhibitors, competition for nutrients, 
and competition for receptor binding sites. It is also pos-
sible that the presence of 1 bacteria species could create 
a more hospitable niche for another bacteria species. We 
were unable to evaluate the precise molecular mechanisms 
that mediate these complex polymicrobial interactions, an 
important area for future research. 
Our study had several strengths, including its longi-
tudinal, prospective design. We examined nasopharyngeal 
carriage during URI, a time when children are at risk for 
secondary bacterial infections. In addition, we took advan-
tage of repeated measures analytic techniques to examine 
microbe-level factors inﬂ   uencing bacterial colonization 
while controlling for host factors. 
Results from our study have public health implica-
tions. Scientists have debated whether they should seek to 
eradicate disease by preventing nasopharyngeal coloniza-
tion (34). Vaccines targeting nasopharyngeal carriage of 
S. pneumoniae, H. inﬂ  uenzae, and M. catarrhalis may be 
needed to prevent otitis media because simultaneous car-
riage of these 3 bacteria may increase risk for otitis media 
(35). Our data indicate that the elimination of nasopha-
ryngeal colonization with bacteria such as S. pneumoniae 
and H. inﬂ  uenzae may increase risk for colonization with 
S. aureus. Scientists conducting a randomized trial of 
the effectiveness of pneumococcal vaccines noted an in-
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crease in S. aureus when spontaneously draining infected 
middle ears of vaccinated children (25). Factors that may 
increase the risk of colonization with S. aureus are of spe-
cial concern given the spread of methicillin-resistant S. 
aureus (9). Researchers are attempting to develop an S. 
pneumoniae vaccine containing pneumococcal choline 
binding protein A, which would protect against sepsis and 
pneumonia without interfering with pneumococcal colo-
nization (36). Although this type of vaccination strategy 
may eventually decrease the incidence of potentially fatal 
invasive pneumococcal disease, it is unlikely to prevent 
otitis media. Thus, the public health impact of a given 
intervention strategy may be hard to predict, and caution 
should be used when designing control strategies that tar-
get nasopharyngeal colonization.
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